These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28087782)

  • 21. Prevalence of plasmid-mediated quinolone resistance determinants among Escherichia coli isolated from food animals in Korea.
    Tamang MD; Nam HM; Chae MH; Kim SR; Gurung M; Jang GC; Jung SC; Lim SK
    Foodborne Pathog Dis; 2012 Dec; 9(12):1057-63. PubMed ID: 23186547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of novel mutations involved in quinolone resistance in Escherichia coli isolated from imported shrimp.
    Nawaz M; Sung K; Kweon O; Khan S; Nawaz S; Steele R
    Int J Antimicrob Agents; 2015 May; 45(5):471-6. PubMed ID: 25631675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of ciprofloxacin resistance and clonal relatedness of clinical Escherichia coli isolates from haematology patients receiving ciprofloxacin prophylaxis.
    van Hees BC; Tersmette M; Willems RJ; de Jong B; Biesma D; van Hannen EJ
    J Antimicrob Chemother; 2011 Aug; 66(8):1739-44. PubMed ID: 21636586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolutionary action of mutations reveals antimicrobial resistance genes in Escherichia coli.
    Marciano DC; Wang C; Hsu TK; Bourquard T; Atri B; Nehring RB; Abel NS; Bowling EA; Chen TJ; Lurie PD; Katsonis P; Rosenberg SM; Herman C; Lichtarge O
    Nat Commun; 2022 Jun; 13(1):3189. PubMed ID: 35680894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli.
    Bachoual R; Tankovic J; Soussy CJ
    Microb Drug Resist; 1998; 4(4):271-6. PubMed ID: 9988045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantifying the contribution of four resistance mechanisms to ciprofloxacin MIC in Escherichia coli: a systematic review.
    van der Putten BCL; Remondini D; Pasquini G; Janes VA; Matamoros S; Schultsz C
    J Antimicrob Chemother; 2019 Feb; 74(2):298-310. PubMed ID: 30357339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluoroquinolone Resistance Mechanisms by Molecular Epidemiologic Study of Ciprofloxacin-Nonsusceptible
    Yang HS; Kim Y; Cho SY; Nam YS; Oh TS; Park KS; Kim HC; Lee HJ
    Ann Clin Lab Sci; 2017 Aug; 47(4):511-515. PubMed ID: 28801381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin-resistant Escherichia coli in hospital wastewater of Bangladesh and prediction of its mechanism of resistance.
    Akter F; Amin MR; Osman KT; Anwar MN; Karim MM; Hossain MA
    World J Microbiol Biotechnol; 2012 Mar; 28(3):827-34. PubMed ID: 22805801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MECHANISMS OF RESISTANCE TO CIPROFLOXACIN AND GENETIC DIVERSITY OF ESCHERICHIA COLI STRAINS ORIGINATING FROM URINE CULTURES PERFORMED FOR ROMANIAN ADULTS.
    Cristea VC; Oprea M; Neacşu G; Gîlcă R; Popa MI; Usein CR
    Roum Arch Microbiol Immunol; 2015; 74(3-4):73-8. PubMed ID: 27328520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
    Lee MY; Choi HJ; Choi JY; Song M; Song Y; Kim SW; Chang HH; Jung SI; Kim YS; Ki HK; Son JS; Kwon KT; Heo ST; Yeom JS; Shin SY; Chung DR; Peck KR; Song JH; Ko KS
    J Infect; 2010 Feb; 60(2):146-53. PubMed ID: 19932131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes.
    Cesaro A; Bettoni RR; Lascols C; Mérens A; Soussy CJ; Cambau E
    J Antimicrob Chemother; 2008 May; 61(5):1007-15. PubMed ID: 18325893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli.
    Johnson JR; Johnston B; Kuskowski MA; Sokurenko EV; Tchesnokova V
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4471-80. PubMed ID: 25987621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
    Cavaco LM; Frimodt-Møller N; Hasman H; Guardabassi L; Nielsen L; Aarestrup FM
    Microb Drug Resist; 2008 Jun; 14(2):163-9. PubMed ID: 18500921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli.
    Machuca J; Briales A; Labrador G; Díaz-de-Alba P; López-Rojas R; Docobo-Pérez F; Martínez-Martínez L; Rodríguez-Baño J; Pachón ME; Pascual A; Rodríguez-Martínez JM
    J Antimicrob Chemother; 2014 Dec; 69(12):3203-15. PubMed ID: 25139837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ciprofloxacin selects for RNA polymerase mutations with pleiotropic antibiotic resistance effects.
    Pietsch F; Bergman JM; Brandis G; Marcusson LL; Zorzet A; Huseby DL; Hughes D
    J Antimicrob Chemother; 2017 Jan; 72(1):75-84. PubMed ID: 27621175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of aminoacyl-tRNA synthetase mutations on susceptibility to ciprofloxacin in Escherichia coli.
    Garoff L; Huseby DL; Praski Alzrigat L; Hughes D
    J Antimicrob Chemother; 2018 Dec; 73(12):3285-3292. PubMed ID: 30239743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictable properties of fitness landscapes induced by adaptational tradeoffs.
    Das SG; Direito SO; Waclaw B; Allen RJ; Krug J
    Elife; 2020 May; 9():. PubMed ID: 32423531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.